Biofrontera Inc.
BFRI
$0.86
$0.0121.42%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -31.62% | 39.36% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -31.62% | 39.36% | |||
| Cost of Revenue | -38.01% | 8.10% | |||
| Gross Profit | -26.99% | 76.23% | |||
| SG&A Expenses | 5.40% | -2.49% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.96% | 2.14% | |||
| Operating Income | -165.60% | 65.48% | |||
| Income Before Tax | -200.50% | 75.31% | |||
| Income Tax Expenses | 66.67% | -200.00% | |||
| Earnings from Continuing Operations | -201.07% | 75.37% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -201.07% | 75.37% | |||
| EBIT | -165.60% | 65.48% | |||
| EBITDA | -169.25% | 65.27% | |||
| EPS Basic | -156.69% | 81.21% | |||
| Normalized Basic EPS | -21.01% | 60.09% | |||
| EPS Diluted | -28.17% | 62.37% | |||
| Normalized Diluted EPS | -21.01% | 60.09% | |||
| Average Basic Shares Outstanding | 17.28% | 31.04% | |||
| Average Diluted Shares Outstanding | 17.28% | 31.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||